// App-Quantinova.ai

BSH2020‐PO‐169 : A fast and simple UPLC‐MS/MS method for the simultaneous quantification of apixaban, edoxaban and rivaroxaban in human plasma and breast milk: for investigating direct oral anticoagulants in emerging lactation studies

Researchers

Presenter

  • Y. Zhao

Principal Investigators

  • L. Couchman

  • K. Kipper

  • R. Arya

  • J. P. Patel

Medical Centers

  • Institute of Pharmaceutical Science, King's College London

  • King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom

  • Analytical Services International Ltd, London, UK

  • Institute of Chemistry, University of Tartu, Tartu, Estonia

Locations

  • United Kingdom

  • Estonia

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • apixaban

  • Edoxaban

  • Heparin

  • Lithium

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved